Gilead quarterly profit falls as COVID antiviral sales decrease
Go back to Gilead quarterly profit falls as COVID antiviral sales decrease| Gilead Sciences (NASDAQ: GILD) | Delayed: 126.33 -1.55 (1.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $127.88 | 52 Week High | $108.63 | |||
| Open | $128.86 | 52 Week Low | $71.39 | |||
| Day High | $128.86 | P/E | 69.80 | |||
| Day Low | $125.49 | EPS | $1.81 | |||
| Volume | 6,897,682 | |||||
